Sorting by: date (All)
Date
Rank
Live rank
Popular

News tagged with abiraterone

FDA approves Akeega for BRCA-positive metastatic prostate cancer

Aug 18, 2023

FDA approves lynparza for BRCA-mutated metastatic castration-resistant prostate cancer

Jun 7, 2023

Black men with metastatic prostate cancer may benefit from drug combination

Jun 1, 2023

Guideline updated for initial management of advanced prostate cancer

Apr 12, 2023

National prostate cancer trial currently testing therapy based on molecular discovery

Jan 17, 2023

Researchers identify drug resistance factors for advanced prostate cancer

Sep 22, 2022

Common prostate cancer medications may be less safe than previously thought

May 25, 2022

Abiraterone could halve risk of prostate cancer death for some patients

Dec 28, 2021

Prostate cancer treatment: An encouraging combination therapy

Nov 3, 2021

Mutations in CTC may predict outcomes in some castrate-resistant prostate cancer patients

Mar 26, 2021
Load more